Table 2 Baseline characteristics of ESCC patients and the correlation with RABL6 expression
Characteristics | Total [cases (%)] | RABL6 expression [cases (%)] | P value | |
|---|---|---|---|---|
N = 171 | High N = 96 | Low N = 75 |  | |
Age (years) | Â | Â | Â | 0.040 |
 ≤ 55 | 79 (46.2) | 45 (26.3) | 34 (19.9) |  |
 > 55 | 92 (53.8) | 51 (29.8) | 41 (24.0) |  |
Gender | Â | Â | Â | 0.320 |
 Male | 129 (75.4) | 74 (43.2) | 55 (32.2) |  |
 Female | 42 (24.6) | 22 (12.9) | 20 (11.7) | |
Tumor location | Â | Â | Â | 0.132 |
 Upper | 13 (7.6) | 8 (4.7) | 5 (2.9) |  |
 Middle | 114 (66.7) | 69 (40.4) | 45 (26.3) |  |
 Low | 44 (25.7) | 19 (11.1) | 25 (14.6) |  |
Lymph-vascular invasion | Â | Â | Â | 0.000 |
 Yes | 79 (46.2) | 56 (32.7) | 23 (13.5) |  |
 No | 92 (53.8) | 40 (23.4) | 52 (30.4) |  |
Perineural invasion | Â | Â | Â | 0.139 |
 Yes | 63 (36.8) | 40 (23.4) | 23 (13.5) |  |
 No | 108 (63.2) | 56 (32.7) | 52 (30.4) |  |
Histological differentiation | Â | Â | Â | 0.282 |
 Well | 39 (22.8) | 22 (12.9) | 17 (9.9) |  |
 Moderate | 93 (54.4) | 48 (28.1) | 45 (26.3) |  |
 Poor | 39 (22.8) | 26 (15.2) | 13 (7.6) |  |
Pathological stage | Â | Â | Â | 0.374 |
 I & II | 103 (60.2) | 55 (32.2) | 48 (28.1) |  |
 III & IV | 68 (39.8) | 41 (23.9) | 27 (15.8) |  |
Lymph node metastasis | Â | Â | Â | 0.162 |
 No | 90 (52.6) | 46 (26.9) | 44 (25.7) |  |
 Yes | 81 (47.4) | 50 (56.1) | 31 (18.1) |  |